CRISPR Medicine News, 26 June 2020 | Your Missing Links - CRISPR Medicine

Your missing links are here

Top picks




  • UC Riverside engineers are using supercomputers to investigate rapid, CRISPR-based COVID-19 tests.
  • CRISPR-Cas9 screen reveals host genes that aid SARS-CoV-2 infection. The discovery could assist in the development of new therapies, and reveal why some people are more susceptible to COVID-19 than others.
  • How medicine makers personal and professional lives have changed over the course of the COVID-19 crisis. Featuring Simon Tyler at CatSci, Nick Shackley at Johnson Matthey, Chris Lowe at Horizon Discovery, and Andrew Bulpin at Merck.

Clinical trials

Vision and opinion

  • World Economic Forum 17 bids on how technology could change the world by 2025, including from Rahul Dhanda, Co-Founder and CEO of Sherlock Biosciences. »Engineering biology, machine learning and the sharing economy will establish a framework for decentralising the healthcare continuum, moving it from institutions to the individual.« We recently interviewed Dhanda about the first-ever FDA-approved CRISPR kit for COVID19 detection.
  • The Conversation: Gene therapy and CRISPR strategies for curing blindness (Yes, you read that right).


Heh, huh, wow

  • Meet the family working with scientists to fight rare diseases with CRISPR therapy. Video [04:43 min].

Reminder: 50% discount on CRISPR Medicine News: You may take advantage of this discount using the promo code: CMN2020 when you follow this link:

The deadline for the 50% offer is 1st August 2020.

Remember, all students have free access to all content on CRISPR Medicine News. Our newsletter will also stay free, and new articles will be open to read for the first three days.

Thank You for now.

And if you have questions or suggestions, you can directly reach us at We love hearing from readers!

(c; Rasmus


You can follow the blog on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up yourself here.